NIA Impact Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$254K Sell
2022
Q4
$334K Sell
2022
Q3
$842K Sell
2022
Q2
$2.74M Sell
2022
Q1
$5.03M Buy
2021
Q4
$3.88M Buy
2021
Q3
$6.77M Buy
2021
Q2
$6.46M Buy
2021
Q1
$4.62M Buy
2020
Q4
$6.51M Buy